US Edition
Lilly’s Obesity Drug Sales Rise 60% in India Amid Rising Demand
- The UK’s MHRA has alerted women taking GLP-1 medications after receiving reports of 40 unintended pregnancies associated with these drugs.
- The warning followed reports that relying on birth control with GLP-1 therapy carries heightened pregnancy risks, though data on effects during pregnancy remain limited.
- Doctors emphasize GLP-1 injections treat medical conditions like obesity and diabetes, cautioning against their use solely for cosmetic weight loss due to associated pregnancy and miscarriage risks.
- Eli Lilly introduced Mounjaro in India this March to address both diabetes and obesity, with unit sales increasing from 11,640 in March to 42,280 in May, generating nearly ₹24 crore in revenue during the first three months.
- The obesity treatment market in India could reach ₹25,000 crore by 2030, and experts expect clearer trends on GLP-1 drugs’ role in weight management to emerge soon.
12 Articles
12 Articles
Lilly’s Obesity Drug Sales Rise 60% in India Amid Rising Demand
Eli Lilly & Co. increased sales of weight-loss and diabetes drug Mounjaro 60% in India in May from April in its second full month of being on offer in the South Asian country, which has the world’s third-highest number of obese people.
The British medicines watchdog is warning women that slimming drugs such as Ozempic and Mounjaro can reduce the effectiveness of the pill. Forty women have already become pregnant, and in the UK there is even talk of ‘Ozempic babies’. Women are advised to use extra contraception such as condoms.
Women on Weight Loss Drugs Are Having ‘Ozempic Babies’
Ozempic, Wegovy, Mounjaro, and all the other new GLP-1 weight loss drugs are able to miraculously shed pounds. But it seems like they may be canceling out the effects of birth control, too. The UK’s Medicines and Healthcare Products Regulatory Agency, or MHRA, has just issued a warning to women using these medications. They’re letting them know that dozens of women got pregnant, often unintentionally, while using these drugs. These drugs work by…
Women who use slimming drugs such as Ozempic and Mounjaro to lose weight should be careful about which contraceptive they use. The British medicines watchdog has warned of this after at least forty babies were conceived while taking slimming drugs.
Taking Ozempic during pregnancy can harm the fetus. Weight loss injections can also make women pregnant – even if they are using the pill. Now the British Medicines Agency is issuing a warning.
Health authorities in the UK issued a warning on prescription drugs to treat metabolic conditions, while fertility specialists warn that certain treatments may alter hormonal balance
Coverage Details
Bias Distribution
- 43% of the sources lean Left, 43% of the sources lean Right
To view factuality data please Upgrade to Premium
